Caffeine and paraxanthine HPLC assay for CYP1A2 phenotype assessment using saliva and plasma.
about
Structure-Bioactivity Relationships of Methylxanthines: Trying to Make Sense of All the Promises and the DrawbacksInfluence of environmental and genetic factors on CYP1A2 activity in individuals of South Asian and European ancestry.Diurnal variation in CYP1A2 enzyme activity in South Asians and Europeans.Pharmacokinetics of Caffeine following a Single Administration of Coffee Enema versus Oral Coffee Consumption in Healthy Male SubjectsMetabolomics evaluation of serum markers for cachexia and their intra-day variation in patients with advanced pancreatic cancerSemen quality: variations among fathers and effects of moderate alcohol drinking.Development and validation of a reversed-phase HPLC method for CYP1A2 phenotyping by use of a caffeine metabolite ratio in saliva.Assessment of CYP1A2 enzyme activity in relation to type-2 diabetes and habitual caffeine intake.Breath tests to phenotype drug disposition in oncology.Caffeine decreases intermittent hypoxia in preterm infants nearing term-equivalent age.Salivary caffeine concentrations are comparable to plasma concentrations in preterm infants receiving extended caffeine therapy.Pregnancy-induced changes in the pharmacokinetics of caffeine and its metabolites.Post-study caffeine administration enhances memory consolidation in humans.A case-control field study on the relationships among type 2 diabetes, sleepiness and habitual caffeine intake.HPLC Method for Quantification of Caffeine and Its Three Major Metabolites in Human Plasma Using Fetal Bovine Serum Matrix to Evaluate Prenatal Drug ExposureMonitoring Caffeine in Human Saliva Using a Newly Developed ELISA
P2860
Q26740559-02FE4906-D89C-4561-BFE7-E9312218CEB3Q34297580-F63A56A6-B595-4E36-B3E3-342742C2DFD8Q34320302-5CE1E882-408B-469E-A71C-D6676E26F723Q34335542-8DA9FE9C-2CB8-477A-91DF-63497D96D744Q34549970-8E6414E8-C98B-4FE2-B567-D26DDB3C3C74Q34927921-B14385A8-5D3C-42DE-8FA0-4FFDD1362B8EQ35609358-71622F2C-8801-400C-AAD2-0FC47A2E616EQ37315406-7751B06D-1D07-44AD-93D9-6C665C00B1EEQ38122635-B9FF6A92-92A1-4827-BF5E-F9C2FEB5238FQ38657845-738CA92C-445A-4C22-A60F-150B28D80E68Q40769061-752EA2D7-06F4-421F-BDC3-A9024BF2AE83Q41469292-5B94A2DC-81E4-488F-B49E-E6EAE2717F8BQ46059594-8FD62850-89EB-439E-BDFD-5B6E2C271139Q47814503-D1874E1A-F53D-4910-8EC2-88597BC55658Q57169794-2C7815DC-3DC4-4323-BBA5-95ABD48807C5Q58279301-064E2D39-422C-4851-95F9-917D2B808A5F
P2860
Caffeine and paraxanthine HPLC assay for CYP1A2 phenotype assessment using saliva and plasma.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Caffeine and paraxanthine HPLC ...... sment using saliva and plasma.
@ast
Caffeine and paraxanthine HPLC ...... sment using saliva and plasma.
@en
type
label
Caffeine and paraxanthine HPLC ...... sment using saliva and plasma.
@ast
Caffeine and paraxanthine HPLC ...... sment using saliva and plasma.
@en
prefLabel
Caffeine and paraxanthine HPLC ...... sment using saliva and plasma.
@ast
Caffeine and paraxanthine HPLC ...... sment using saliva and plasma.
@en
P2860
P356
P1476
Caffeine and paraxanthine HPLC ...... ssment using saliva and plasma
@en
P2093
Annette S Gross
P2860
P304
P356
10.1002/BMC.1419
P577
2010-10-01T00:00:00Z